Interactions of proteins in the Bluetongue virus core

蓝舌病毒核心蛋白质的相互作用

• 批准号: 7528822
• 负责人: POLLY ROY
• 金额: $ 28.64万
• 依托单位: LONDON SCH/HYGIENE & TROPICAL MEDICINE
• 依托单位国家: 美国
• 财政年份: 2000
• 资助国家: 美国
• 起止时间: 2000-02-01 至 2012-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7528822
• 关键词: Affect; Animals; Architecture; Area; Biochemical; Biochemical Reaction; Biological Assay; Biology; Bluetongue virus; Capsid; Cells; Complex; Core Protein; Crystallization; Dissection; Enzyme Kinetics; Enzymes; Family member; Genetic; Genetic Transcription; Genome; Goals; High Pressure Liquid Chromatography; Human; In Vitro; Insect Proteins; Kinetics; Lead; Localized; Mammalian Orthoreovirus; Minor; Molecular; Molecular Machines; Mutagenesis; Nucleosome Core Particle; Orbivirus; Play; Polymerase; Proteins; Public Health; RNA-Directed RNA Polymerase; Reaction; Reagent; Recombinant Proteins; Recombinants; Reoviridae; Reoviridae Infections; Reovirus; Research; Resolution; Rest; Roentgen Rays; Role; Spectrum Analysis; Structural Protein; Structure; Structure-Activity Relationship; Surface Plasmon Resonance; System; Tertiary Protein Structure; Transcript; Transcriptase; Viral; Viral Genome; Viral Proteins; Virus; Virus Replication; Viviparous-1 protein; Work; X ray diffraction analysis; X-Ray Crystallography; X-Ray Diffraction; base; design; enzyme activity; helicase; in vitro Assay; inhibitor/antagonist; light scattering; man; member; nanomachine; positional cloning; programs; protein expression; protein protein interaction; protein structure; reconstitution; rice dwarf virus; single molecule; three-dimensional modeling; virus core

DESCRIPTION (provided by applicant): Upon cell infection, Reoviridae capsids never completely disassemble, and viral transcripts are extruded from the icosahedral core particle. As a consequence the core must contain all the necessary enzymatic reactions for transcription and capping. The interactions between viral proteins and between these proteins and the viral genome in the core, is highly specific and the core may be considered to function as a precise molecular machine. Atomic structures for the cores of three members of this family (Bluetongue virus, Rice dwarf virus and mammalian orthoreovirus) are available, and are among the largest structures solved by X- ray diffraction. However, the core architecture of BTV (and RDV) is different with only reovirus having defined capping turrets. For BTV, capping protein is co-localised with the RNA-dependent-RNA-polymerase (RdRp) at the fivefold vertices of the core. Although the transcription complex within the core has been localised, it was not possible to resolve its structural details from the crystal structure. The objective of this application is to provide a complete structural and biochemical understanding of how the BTV transcription complex functions. Completion of this goal will pave the way for the rational design of inhibitors to block orbivirus replication and provide lead compounds for related viruses of pathogenic significance. Furthermore, the work will contribute to the growing areas of understanding the structural basis of transcription and for understanding how complex machines can be constructed from modular protein-based units. BTV is uniquely placed to deliver this information. It is the only non-turreted member of the Reoviridae for which an atomic core structure and complete in vitro activity of purified recombinant enzymatic proteins is available. The proposed research will build on these reagents and on our recent crystal structure of the BTV capping enzyme to understand the molecular basis of enzyme function and how the enzymatic proteins of the core act in concert to achieve transcription. In Specific Aim 1 we will undertake a detailed program of mutagenesis, biochemical and biophysical studies to understand the structure-function relationships of the four enzymatic activities of the capping enzyme. Specific Aim 2 will focus on the protein-protein interactions between the capping and RdRp proteins, and between these proteins and the major structural proteins of the core. Specific Aim 3 will focus on structure-function studies of the core associated viral helicase protein to understand if this protein is functional in transcription or packaging of the viral genome. Finally, in Specific Aim 4 recombinant proteins will be used to reconstitute viral transcription complexes in vitro to understand how these proteins interact with and affect the activity of each other. In all approaches we will use a combination of structural (NMR, cryo-EM, X-ray crystallography, dynamic and static light scattering) and biochemical (single molecule kinetic studies, mutagenesis, Raman and IR spectroscopy, HPLC, enzyme assays to follow kinetics, surface plasmon resonance) approaches. PUBLIC HEALTH RELAVANCE: The project aims to provide a complete understanding of how a complex virus functions as a nanomachine. Completion of this goal will pave the way for the rational design of inhibitors to block virus (in particular, an animal virus) replication and provide lead compounds for related viruses of pathogenic significance to humans and animals.

描述（由申请方提供）：细胞感染后，呼肠孤病毒科衣壳从未完全分解，病毒转录物从二十面体核心颗粒中挤出。因此，核心必须包含转录和加帽所需的所有酶促反应。病毒蛋白之间以及这些蛋白与核心中的病毒基因组之间的相互作用是高度特异性的，并且核心可以被认为是作为精确的分子机器起作用。该家族的三个成员（蓝舌病毒、水稻矮缩病毒和哺乳动物正呼肠孤病毒）的核心的原子结构是可用的，并且是通过X射线衍射解析的最大结构之一。然而，BTV（和RDV）的核心结构是不同的，只有呼肠孤病毒具有限定的加帽塔。对于BTV，加帽蛋白与RNA依赖性RNA聚合酶（RdRp）共定位在核心的五个顶点处。虽然核心内的转录复合物已经被定位，但不可能从晶体结构中解析其结构细节。本申请的目的是提供一个完整的结构和生物化学的理解如何BTV转录复合物的功能。这一目标的完成将为合理设计阻断环状病毒复制的抑制剂铺平道路，并为具有致病意义的相关病毒提供先导化合物。此外，这项工作将有助于理解转录的结构基础和理解如何从模块化蛋白质基单元构建复杂机器的不断增长的领域。BTV是唯一能够提供这些信息的地方。它是呼肠孤病毒科中唯一具有原子核心结构和纯化重组酶蛋白完整体外活性的非塔状成员。拟议的研究将建立在这些试剂和我们最近的BTV加帽酶的晶体结构上，以了解酶功能的分子基础以及核心的酶蛋白如何协同作用以实现转录。在具体目标1中，我们将进行详细的诱变，生物化学和生物物理研究计划，以了解加帽酶的四种酶活性的结构-功能关系。具体目标2将集中在蛋白质-蛋白质之间的相互作用的帽子和RdRp蛋白质，以及这些蛋白质和核心的主要结构蛋白质。具体目标3将侧重于核心相关病毒解旋酶蛋白的结构-功能研究，以了解这种蛋白质是否在病毒基因组的转录或包装中发挥作用。最后，在特定目标4中，重组蛋白将用于在体外重建病毒转录复合物，以了解这些蛋白质如何相互作用并影响彼此的活性。在所有方法中，我们将使用结构（NMR、cryo-EM、X射线晶体学、动态和静态光散射）和生物化学（单分子动力学研究、诱变、拉曼和IR光谱、HPLC、酶测定以跟踪动力学、表面等离子体共振）方法的组合。公共卫生关系：该项目旨在全面了解复杂病毒如何作为纳米机器发挥作用。这一目标的完成将为合理设计抑制剂以阻断病毒（特别是动物病毒）复制铺平道路，并为对人类和动物具有致病意义的相关病毒提供先导化合物。